Medicenna Therapeutics Corp.
MDNA.TO
TSX
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 10.24% | -28.79% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -0.08% | 8.95% | |||
Operating Income | 0.08% | -8.95% | |||
Income Before Tax | -530.64% | 122.30% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -530.64% | 122.30% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -530.64% | 122.30% | |||
EBIT | 0.08% | -8.95% | |||
EBITDA | 0.32% | -8.90% | |||
EPS Basic | -507.55% | 122.32% | |||
Normalized Basic EPS | -509.09% | 122.22% | |||
EPS Diluted | -507.55% | 122.32% | |||
Normalized Diluted EPS | -509.09% | 122.22% | |||
Average Basic Shares Outstanding | 5.55% | 0.23% | |||
Average Diluted Shares Outstanding | 5.55% | 0.23% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |